Stanton Mccomb

Stanton Mccomb is the President, Medical-Surgical of McKesson. Stanton has been with the company since January 2002 and in their current role since December 2004.

Previously, Stanton was the Director, Corporate Strategy for McKesson from January 2002 to December 2004. In this role, they provided enterprise-wide consulting and M&A support to business units and consulted with executive leadership teams on growth, portfolio and partnership strategies.

Before joining McKesson, Stanton was a Portfolio Manager & Interim CEO of Portfolio Company at Citigroup Investments from January 1999 to December 2002. Stanton started as manager of a $400M investment portfolio of early-stage healthcare companies within Citigroup’s venture capital business and then served as interim CEO for a portfolio business. Stanton closed U.S. operations, relocated to England to focus on European opportunities and sold the business to AMS, a U.K.-based wound care company.

Stanton began their career as a Senior Manager, Custom Research at Advisory Board Company from January 1995 to December 1997. Stanton then spent three years as a Volunteer with the Peace Corps from January 1992 to December 1995.

Stanton Mccomb has a MBA from Northwestern University - Kellogg School of Management and a BA from Villanova University.

Stanton Mccomb reports to Brian Tyler, CEO. Some of their coworkers include Derek Rago - VP & GM of McKesson Data, Evidence & Insights, Kelvin Baggett - Executive Vice President & Chief Impact Officer, and Nathan Mott - President, Prescription Technology Solutions.